Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,766 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06650852RecruitingPhase 2
A study of 3 drugs for chronic hepatitis B
This trial tests a combination of three drugs (BRII-179, BRII-835, and PEG-IFNα) to see if they can better control chronic hepatitis B. It is for people who are already on antiviral therapy and have well-controlled virus levels.
Beijing, Beijing MunicipalityAges 18–60 - NCT06655272RecruitingPhase 4
OM 85 to prevent lung infections in older nursing home residents
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
Roma, RMAges 75 years+ - NCT06656104Recruiting
Multi-infusion strategy effect on bloodstream infections in premature babies
This trial tests whether a special method of giving multiple IV medicines at the same time can reduce serious bloodstream infections in premature babies. The study focuses on very small and early-born infants who need several infusions.
Bron, FranceAges Up to 7 months - NCT06676410RecruitingPhase 2
Testing Codivir plus standard HIV treatment in new patients
This trial tests a new investigational drug called Codivir added to standard HIV treatment for people who have never taken HIV medications before. It aims to see if adding Codivir helps control the virus better and is safe.
São PauloAges 18 years+ - NCT06678113RecruitingPhase 1/Phase 2
Testing a new IV drug for serious fungal infections
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
Dehli, HaryanaAges 18–100 - NCT06684379RecruitingPhase 1/Phase 2
Two Doses of PRS CK STORM for Severe Viral Pneumonia
This study tests a new drug called PRS CK STORM to see if it can safely calm the body's overactive immune response (cytokine storm) in people with severe pneumonia from COVID-19, flu, or RSV who need oxygen. It aims to reduce inflammation and improve recovery.
Alcalá de Henares, MadridAges 18 years+ - NCT06702449RecruitingPhase 1/Phase 2
UTI vaccine safety and immune response study for adults 18-64
This trial tests a new vaccine to prevent urinary tract infections (UTIs). It first checks safety and immune response in healthy adults, then in women with recent E. coli UTIs. The goal is to see if the vaccine can reduce future infections.
Lenexa, KansasAges 18–64 - NCT06703918Recruiting
C. Diff Infection Study in Babies
This study looks at Clostridium difficile (C. diff) infections in babies under 2. It compares babies who have the infection with those who don't, using medical records to learn more about how it affects them.
Hangzhou, Zhejiang, ChinaAges birth–2 years - NCT05783661RecruitingPhase 4
Antibiotic plan guided by infection tracking in cirrhosis
This study compares standard antibiotic treatment versus antibiotic choices guided by local infection tracking (epidemiological surveillance) in people with cirrhosis who have an acute worsening and likely a bacterial infection. It may help doctors choose antibiotics more accurately and safely in this high-risk situation.
BarcelonaAges 18 years+ - NCT06976125Recruiting
Using a model to guide antibiotic choice for UTI after ER visit
This trial tests whether a prediction model can help doctors choose the right antibiotic for women with a urinary tract infection (UTI) after an emergency room visit. It aims to improve treatment and reduce unnecessary antibiotics.
Cleveland, OhioAges 18 years+ - NCT07275307Recruiting
Test of a wound gel to prevent infections after heart surgery
This study tests whether a special gel applied to the chest incision during heart surgery can lower the chance of wound infections. The gel may help keep the incision site clean and help it heal better.
San Donato Milanese, MichiganAges 18 years+ - NCT06711861Recruiting
Study of streptobacillus infections in France
This study looks back at cases of a rare bacterial infection called Streptobacillus moniliformis in France between 2007 and 2023. It aims to better understand how the infection affects people of all ages.
StrasbourgAges 1 year+ - NCT06713382RecruitingPhase 2
Saline rinse for trapped lung infections
This trial tests if adding a simple saltwater rinse to standard chest tube drainage helps clear stubborn lung infections. It might be an option if you have an infected fluid pocket in your chest that isn't draining well.
Boston, MassachusettsAges 18 years+ - NCT06716450Recruiting
HIV and syphilis self-test study
This study tests a new self-test for HIV and syphilis that you can do yourself at a clinic or community site. It is for people who do not know if they have HIV or syphilis and have not tested positive before.
Victoria, British ColumbiaAges 18 years+ - NCT06717581Recruiting
Drug interaction study for older people with HIV
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
BolognaAges 18 years+ - NCT06726395RecruitingPhase 4
Comparing two antibiotics for staph bloodstream infection
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
LundAges 18 years+ - NCT06738407RecruitingPhase 4
Doxycycline to prevent STIs in high-risk people
This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.
Los Angeles, CaliforniaAges 13–29 - NCT06751836Recruiting
New ways to treat severe dengue
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Guatemala CityAges 18 years+ - NCT06752161Recruiting
Urinary infection in pregnant women with preterm labor
This trial studies urinary tract infections in pregnant women who are experiencing preterm labor. The goal is to understand how these infections may affect early contractions and pregnancy outcomes.
AsyutAges Any age - NCT06771843Recruiting
Helping men with HIV reduce drinking and improve HIV prevention
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
KampalaAges 18 years+ - NCT06775808Recruiting
Understanding eye infections through DNA testing
This study looks at eye infections by testing leftover fluid or tissue samples to find all possible germs, including viruses, bacteria, and fungi. It may help doctors better understand what causes different eye infections and improve treatment.
Shanghai, Shanghai MunicipalityAges Any age - NCT06780813Recruiting
High flow oxygen to reduce infections in obese gynecologic cancer patients
This trial tests whether giving high flow oxygen during and after surgery can lower the risk of infections in obese women with gynecological cancer. It may help improve recovery after surgery.
AthensAges 18–85 - NCT06805994RecruitingPhase 1
Restoring infant nose bacteria after staph treatment
This study tests whether giving a nasal spray of healthy bacteria to infants can restore good germs in the nose after they receive mupirocin ointment to treat Staph aureus. It aims to bring back a healthy nasal microbiome.
Baltimore, MarylandAges birth–60 years - NCT06807840Recruiting
Flu infection study at Penn Medicine
This study looks at how people's immune systems respond to the flu. If you have a positive flu test at a Penn Medicine location and are 18 or older, you may be able to join.
Philadelphia, PennsylvaniaAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,766 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.